Product Information

Product Information

SUNHARBO® (asundexian) tablets

SUNHARBO is indicated in combination with antiplatelet therapy to reduce the risk of stroke in adults with recent non cardioembolic ischemic stroke (NIH Stroke Scale ≤15) or high-risk transient ischemic attack (TIA).

CLICK HERE TO VIEW FULL PRESCRIBING INFORMATION FOR SUNHARBO